IBS-D supplement protocol — peppermint, soluble fibre, and the specific probiotic strains with evidence
Diarrhea-predominant IBS (IBS-D) is a heterogeneous functional disorder: visceral hypersensitivity, accelerated transit, microbiome disturbance, and brain-gut axis dysregulation contribute in varying proportions across patients. The supplement layer is real but narrow — a handful of options have replicated trial evidence in IBS specifically, particularly enteric-coated peppermint oil and a few well-characterised probiotic strains. The honest read: dietary intervention (low-FODMAP under dietitian supervision), prescription antispasmodics, and gut-directed CBT or hypnotherapy generally outperform supplements; supplements work best layered on top, not as the whole strategy.
The supplement layer for IBS-D is real but narrow, and it works best layered on top of low-FODMAP diet, prescription antispasmodics, and gut-directed therapy — not as the whole strategy. Enteric-coated peppermint oil has the most consistent trial evidence for global symptoms and pain, soluble psyllium fibre normalises stool form, and a few named probiotic strains (S. boulardii, B. infantis 35624) outperform multi-strain blends. The key caveat is that some “IBS-D” is actually bile acid diarrhoea or something more serious, so confirm the diagnosis and act on any red flags — bleeding, weight loss, onset after 50 — before relying on supplements.
Read this first. Persistent diarrhoea, blood in stool, unintended weight loss, fever, nocturnal symptoms, or onset after age 50 are red flags requiring evaluation — these symptoms point toward inflammatory bowel disease, infection, microscopic colitis, bile acid diarrhoea, or malignancy, not IBS. A clinical diagnosis of IBS (Rome IV criteria) requires excluding these. Bile acid diarrhoea in particular is commonly mislabelled as IBS-D and is treated with bile acid sequestrants, not supplements.
What actually has trial evidence in IBS-D
Enteric-coated peppermint oil
180–225 mg enteric-coated peppermint oil, 1 capsule three times daily before meals, 4–8 week trial
Peppermint oil's L-menthol relaxes intestinal smooth muscle via calcium-channel blockade and reduces visceral hypersensitivity. Multiple meta-analyses (Khanna 2014; Alammar 2019) support its use for global IBS symptoms and abdominal pain; effect sizes are modest but consistent. Enteric coating is essential — non-enteric-coated peppermint can cause reflux/heartburn. The PERSUADE trial showed greatest benefit in those without significant heartburn at baseline.
Psyllium husk (soluble fibre)
5–10 g/day in divided doses with plenty of water; start at 2.5 g and titrate up
Contrary to the intuition that fibre worsens diarrhoea, soluble fibres like psyllium often improve IBS-D by normalising stool form (water retention in the bowel produces a gel that adds bulk without accelerating transit). The Moayyedi 2014 systematic review supports soluble fibre over insoluble fibre in IBS. Avoid bran and other insoluble fibres in IBS-D — they often worsen symptoms. Start low and titrate; abrupt high-dose fibre commonly causes transient bloating.
Saccharomyces boulardii (CNCM I-745) or Bifidobacterium infantis 35624
S. boulardii: 250–500 mg twice daily. B. infantis 35624: as per Align (~1 billion CFU/day), 4-week trial.
Probiotic effects are strain-specific. S. boulardii has reasonable evidence in IBS-D and is particularly useful in post-antibiotic and post-infectious IBS-D. B. infantis 35624 has the best-replicated IBS data among single-strain probiotics (O'Mahony 2005). Multi-strain "kitchen-sink" probiotics have less convincing IBS-specific evidence; specific named strains are what to look for.
Sunfiber (partially hydrolysed guar gum)
5–6 g/day; mixes invisibly into food/drinks
A low-FODMAP-compatible soluble fibre that ferments more gently than inulin or FOS. Small trials in IBS show improvements in bowel habit normalisation, including in IBS-D specifically. Useful in users who don't tolerate psyllium.
What dominates over supplements — and shouldn't be skipped
Dietary work-up typically delivers larger and more durable benefit than any supplement:
- Low-FODMAP diet — the strongest dietary evidence in IBS; should be done under dietitian supervision (not a "forever" diet — it's an elimination-then-reintroduction protocol).
- Caffeine and alcohol audit — both accelerate colonic transit; cutting these is often more impactful than any supplement.
- Lactose tolerance assessment — lactose intolerance is commonly co-existent; a 2-week dairy elimination is a cheap diagnostic.
- Bile acid diarrhoea screening — up to a third of "IBS-D" patients have undiagnosed bile acid diarrhoea, which responds to bile acid sequestrants (cholestyramine, colesevelam) much better than to any supplement. Discuss SeHCAT or empiric trial of bile acid sequestrant with GI.
- Gut-directed hypnotherapy and CBT — high-quality trial evidence in IBS; particularly useful in users with prominent abdominal pain and visceral hypersensitivity.
- Prescription options — rifaximin for bloating-prominent IBS-D, eluxadoline for moderate-to-severe IBS-D (with safety caveats), and antispasmodics like hyoscine/dicyclomine.
What to skip in IBS-D
- Insoluble fibre supplements (wheat bran, cellulose) — frequently worsen IBS-D symptoms; soluble fibre is the right form.
- High-dose magnesium citrate or oxide for "gut motility" — these are osmotic laxatives and will worsen IBS-D. (Magnesium glycinate for sleep is fine at non-laxative doses.)
- Generic "kitchen-sink" multi-strain probiotics — they're not all equivalent. Strain matters; look for the specific named strains with IBS trial data.
- Prebiotics like inulin and FOS — strongly ferment to short-chain fatty acids and gas; commonly worsen bloating and diarrhoea in IBS. Sunfiber is the better-tolerated alternative.
- "Leaky gut" supplements with glutamine, zinc carnosine, and licorice combinations — leaky gut as marketed is not a clinical entity in IBS; these products lack IBS-specific RCT evidence.
- High-dose vitamin C — large doses produce osmotic diarrhoea and will worsen IBS-D.
- CBD products marketed for IBS — limited RCT evidence in IBS; unregulated dose and content.
What to track
The IBS-SSS (Symptom Severity Score) is the standard validated measure; the Bristol Stool Chart (target type 3–5 in IBS-D) and stool frequency are simpler trackers. Reassess at 8 weeks of any supplement intervention. If IBS-SSS hasn't improved by ≥50 points at 8 weeks, the supplement is not the rate-limiting step.
Practical quick-start. Layer dietary work first (FODMAP elimination under dietitian supervision; caffeine, alcohol, dairy audit). For the supplement layer in IBS-D: enteric-coated peppermint oil 180 mg t.i.d. before meals + psyllium husk 5–10 g/day divided + S. boulardii 250–500 mg twice daily or B. infantis 35624 once daily. 8-week trial with IBS-SSS tracking. Escalate to GI if no meaningful improvement or red-flag symptoms develop.